PINK

Fund Description
Under normal circumstances, the Fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The Fund defines health care companies as companies included in the Global Industry Classification Standard health care sector. The Fund defines equity securities as common stock, preferred stock, or ETFs that invest in the same. The Fund invests in companies without restriction as to capitalization, including micro-capitalization companies. The Fund will invest in 80 100 health care companies. The Fund will use fundamental, bottom-up analysis that seeks to identify high-quality companies and the most compelling investment opportunities. In general, the Fund will follow a growth investment strategy, seeking companies whose earnings are expected to grow faster than inflation and the economy in general. When stock valuations seem unusually high, however, a value approach, which gives preference to seemingly undervalued companies, may be emphasized. The Fund generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems. The Fund may invest in health care companies that do not seek to design or develop treatments for breast cancer.
Fund Profile
Fund Name Simplify Health Care ETF
Fund Exchange Ticker PINK
Fund Sponsor Simplify ETF
Fund ISIN US82889N7729
Net Expense Ratio 0.50 %
Fund Inception Date 7 October 2021
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Active
Index Name Not Applicable
Index Provider Not Applicable
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Value
Continent North America
Key Statistics
Return As of Date 26 November 2021
Asset Under Management 6.49 Million (USD)
1 Month Total Return 0.10 %
Year To Date Return 3.81 %
1 Year Total Return
3 Year Annualized Total Return
NAV 25.95
Share Outstanding 250,001
Top 10 Holdings (24 November 2021)
Constituent Name Constituent Ticker Constituent Type Weighting
UNITEDHEALTH GROUP INC UNH EQUI 0.0846331848
PFIZER INC PFE EQUI 0.0541052184
UNITED THERAPEUTICS CORP UTHR EQUI 0.0517522563
DEXCOM INC USD 0.001 DXCM EQUI 0.0504540113
ZOETIS INC USD 0.01 ZTS EQUI 0.0440400114
ABBOTT LABORATORIES ABT EQUI 0.0431058527
JOHNSON & JOHNSON JNJ EQUI 0.0377497045
Lilly (Eli) & Co. LLY EQUI 0.0332660536
ANTHEM INC USD 0.01 ANTM EQUI 0.0331410573
LIVANOVA PLC LIVN EQUI 0.0322775090